These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 726732)

  • 21. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Investigations of hormonal contraception in the young].
    Huber A
    Ther Ggw; 1976 Mar; 115(3):413-26. PubMed ID: 1265701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum prostaglandin F levels during menstrual cycle in women using oral contraceptives.
    Garg SK
    Int J Clin Pharmacol Ther Toxicol; 1983 Aug; 21(8):431-2. PubMed ID: 6629547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Influence of the depot contraceptive agent Deposiston on carbohydrate metabolism in insulin tolerance test].
    Göretzlehner G; Rudolf K; Töwe J
    Zentralbl Gynakol; 1974 Dec; 96(50):1577-83. PubMed ID: 4456908
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased metabolic clearance of acetaminophen with oral contraceptive use.
    Abernethy DR; Divoll M; Ochs HR; Ameer B; Greenblatt DJ
    Obstet Gynecol; 1982 Sep; 60(3):338-41. PubMed ID: 6897933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertension and oral contraceptives.
    Oparil S
    J Cardiovasc Med; 1981 Apr; 6(4):381, 384-7. PubMed ID: 12263383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NTP Toxicology and Carcinogenesis Studies of Triethanolamine (CAS No. 102-71-6) in F344 Rats and B6C3F1 Mice (Dermal Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Nov; 449():1-298. PubMed ID: 12594526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contraception for the perimenopausal patient.
    Upton GV
    Obstet Gynecol Clin North Am; 1987 Mar; 14(1):207-27. PubMed ID: 3306520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogens and hypertension.
    Weinberger MH
    Compr Ther; 1982 Jun; 8(6):71-5. PubMed ID: 7105645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer.
    Slattery ML; Potter JD; Curtin K; Edwards S; Ma KN; Anderson K; Schaffer D; Samowitz WS
    Cancer Res; 2001 Jan; 61(1):126-30. PubMed ID: 11196149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Significance of hormonal contraceptives for coronary heart disease].
    Gohlke-Bärwolf C
    Herz; 1987 Aug; 12(4):263-75. PubMed ID: 3308662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Longitudinal study of the effect of hormonal contraceptives on clinical parameters of the gingiva. 1. Gingivitis indices and plaque index].
    Arnold M
    Stomatol DDR; 1982 Jan; 32(1):47-52. PubMed ID: 6952623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Changes in the endometrium from the use of hormonal preparations and hormonal contraceptives].
    Jellinek G
    Arkh Patol; 1978; 40(11):36-45. PubMed ID: 736819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hormonal contraception--side effects and surgical aspects (author's transl)].
    Göretzlehner G; Carol W; Köhler G
    Zentralbl Chir; 1980; 105(24):1601-16. PubMed ID: 7015744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Reversibility of alterations induced by sexual steroids in various serum protein fractions, following application of hormonal contraceptives (author's transl)].
    Klinger G; Stelzner A; Börner A; Schubert H; Krause G; Scheler R; Tarnick M; Carol W
    Zentralbl Gynakol; 1980; 102(24):1421-30. PubMed ID: 6164184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Do's and don'ts for a woman who has an abnormal lipid pattern and is taking oral contraceptives].
    Boyet F
    Contracept Fertil Sex (Paris); 1984 Sep; 12(9):1076-7. PubMed ID: 12266510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Oral contraception: disadvantages of estrogen reduction].
    Denis C
    Contracept Fertil Sex (Paris); 1993 Jun; 21(6):481-8. PubMed ID: 12318238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of oral contraceptives on serum lipids gamma-glutamyl transpeptidase, and excretion of d-glucaric acid.
    Hajós P; Berlin I; Intödy Z; Tornyossy M; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):117-23. PubMed ID: 6112206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.